Akèy › Neuropathies sensorielles et autonomes héréditaires › Virginia › Arlington
Etid klinik pou Neuropathies sensorielles et autonomes héréditaires nan Arlington, VA
7 etid pou Neuropathies sensorielles et autonomes héréditaires ap chèche patisipan nan sit nan ak bò kote Arlington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of ACR-2316 in Specific Advanced Solid Tumors
Ap rekriteFaz 1/2
- Next Virginia, Fairfax · 11 mi lwen
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Clinical Trial Site, Fairfax · 11 mi lwen
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi lwen
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi lwen
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- NEXT, Fairfax · 11 mi lwen
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Ap rekriteFaz 1
- Virginia Cancer Specialists, Fairfax · 11 mi lwen
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Ap rekriteFaz 2
- Virginia Cancer Specialists, P.C., Fairfax · 11 mi lwen
Etid Neuropathies sensorielles et autonomes héréditaires nan lòt vil
- San Antonio, TX7 etid
- Nashville, TN6 etid
- Boston, MA6 etid
- New York City, NY6 etid
- Houston, TX5 etid
- Philadelphia, PA5 etid
- Portland, OR4 etid
- Pittsburgh, PA4 etid
- Ann Arbor, MI4 etid
- Washington, DC4 etid
- San Francisco, CA3 etid
- Aurora, CO3 etid
Lòt etid nan Arlington
- Kansè Poumon ki pa ti selil104 etid
- Kansè Metastatik53 etid
- Kansè kolorektal52 etid
- Kansè (tout kalite)48 etid
- Kansè nan tete47 etid
- Kansè ovè46 etid
- Kansè poumon41 etid
- Kansè Endomèt39 etid
- Kansè pankreyas33 etid
- Karsinòm selil skuamèz tèt ak kou26 etid
- Kansè poumon selil ti23 etid
- Kansè lestomak20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.